Staphylococcus IVDs

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Disponível em:

Cepheid Holdings Pty Ltd

Classe:

Class 3

Fabricado por:

Cepheid 904 Caribbean Drive, Sunnyvale, California, 94089 United States Of America

Área terapêutica:

CT797 - Staphylococcus IVDs

Indicações terapêuticas:

The Xpert MRSA and MRSA NxG, is a qualitative IVD for the detection of methicillin-resistant S. aureus DNA from nasal swabs. The test utilizes automated real-time PCR for the amplification of MRSA specific DNA targets. The Xpert MRSA and MRSA NxG is intended to aid in the prevention and control of MRSA infections in healthcare settings. The Xpert MRSA and MRSA NxG are not intended to diagnose, guide, or monitor treatment for MRSA infections, or provide results of susceptibility to methicillin

Status de autorização:

A

Data de autorização:

2014-03-31